Laddar...
Private Payer Coverage Policies for ApoE-e4 Genetic Testing
PURPOSE: ApoE-e4 has a well-established connection to late-onset Alzheimer’s disease (AD) and is available clinically. Yet, there have been no analyses of payer coverage policies for ApoE. Our objective is to analyze private payer coverage policies for ApoE genetic testing, examine the rationales, a...
Sparad:
| I publikationen: | Genet Med |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8035237/ https://ncbi.nlm.nih.gov/pubmed/33420342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41436-020-01042-4 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|